Company intelligence / Profile preview

Ortho MTA

Seoul, South Korea

Ownership: Private
Development stage: Other

Overview

BioMTA is a specialized medical device company focused on the development and manufacturing of advanced bioceramic materials for endodontic and restorative dentistry. The company is best known for its OrthoMTA and RetroMTA products, which are Mineral Trioxide Aggregate (MTA) based materials designed for root canal treatment, perforation repair, and pulp capping. These products are engineered to provide high biocompatibility, excellent sealing ability, and bioactive properties that promote the formation of hydroxyapatite. BioMTA serves the global dental market, providing clinicians with specialized tools for complex endodontic procedures.

Therapeutic areas: Rare DiseasesOther
Modalities: DeviceBiomaterial
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Ortho MTA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ortho MTA.

Explore the full profile